Supreme Court Silence on Abortion Pill Sparks Speculation

The U.S. Supreme Court has not publicly acted on Louisiana's challenge to a federal rule allowing mifepristone prescriptions via telemedicine. Justice Alito's interim order expired, keeping mail dispensation temporarily. The Court considers manufacturers' request to overturn a 5th Circuit decision reinstating in-person clinician visits for mifepristone.

The U.S. Supreme Court missed its deadline to take public action on extending a stay regarding the dispensation of an abortion pill via telemedicine and mail, a challenge led by the state of Louisiana.

The case concerns mifepristone, a medication currently allowed to be prescribed remotely under a rule issued during former President Joe Biden's tenure. Interim orders by Justice Samuel Alito allowed this practice to continue until their expiration.

The nine justices are evaluating an appeal by mifepristone manufacturers aiming to lift a New Orleans-based 5th U.S. Circuit Court of Appeals decision that would enforce in-person clinical visits for obtaining the pill.